Healthcare -
Biotechnology - NASDAQ - US
$ 36.18
1.12 %
$ 3.37 B
Market Cap
-9.8
P/E
CRNX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities CRNX - Crinetics Pharmaceuticals, Inc.
389 M
LAST VALUE
24.07%
2 YEAR CAGR
17.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR